Connection
Nakita Lovelady to United States Food and Drug Administration
This is a "connection" page, showing publications Nakita Lovelady has written about United States Food and Drug Administration.
|
|
Connection Strength |
|
 |
|
 |
|
0.050 |
|
|
|
-
Tobacyk J, Parks BJ, Lovelady N, Brents LK. Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom. Int J Drug Policy. 2022 10; 108:103817.
Score: 0.050